8-K/AThe WireRoutine
Bylaw Amendment
Filed Nov 14, 2023 · 2y ago · Accession 0001213900-23-087115
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Estrella Immunopharma, Inc.
- Ticker
- ESLAW
- CIK
- 1844417
- Form type
- 8-K/A
- Filing date
- Nov 14, 2023
- Report date
- Sep 29, 2023
- Document
- ea188438-8ka1_estrella.htm
- Size
- 269 KB